A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2/3 (CIN2/3)-Reference-Cited by-同舟云学术

A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2/3 (CIN2/3)

Published:2020-04 Issue:1 Volume:157 Page:188-194
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Trimble Cornelia L.,Levinson Kimberly,Maldonado Leonel,Donovan Michael J.,Clark Katharine T.,Fu Jie,Shay Maria E.,Sauter Mary Elizabeth,Sanders Stephanie A.,Frantz Peter S.,Plesa Mihaela

Funder

Frantz Viral Therapeutics

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference36 articles.

1. Global burden of cancers attributable to infections in 2012: a synthetic analysis;Plummer;Lancet Glob. Health,2016

2. Loop electrosurgical excision procedure and the risk for preterm delivery;Heinonen;Obstet. Gynecol.,2013

3. Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence?;Nagai;Gynecol. Oncol.,2000

4. Factors affecting residual/recurrent cervical intraepithelial neoplasia after cervical conization with negative margins;Fan;J. Med. Virol.,2018

5. Risk factors for cervical intraepithelial neoplasia recurrence after conization: a 10-year study;Serati;Eur. J. Obstet. Gynecol. Reprod. Biol.,2012

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Women’s experiences and acceptability of self-administered, home delivered, intravaginal 5-Fluorouracil cream for cervical precancer treatment in Kenya;2024-08-28

2. Looking Back, Moving Forward: Challenges and Opportunities for Global Cervical Cancer Prevention and Control;Viruses;2024-08-25

3. Enhancement of Anticancer Potential of Artemisinin Derivatives through N-glycosylation;Current Topics in Medicinal Chemistry;2024-08-12

4. Anti-Cancer Properties of Two Intravenously Administrable Curcumin Formulations as Evaluated in the 3D Patient-Derived Cancer Spheroid Model;International Journal of Molecular Sciences;2024-08-05

5. Prämaligne Vulvaläsionen: Einteilung, Risikofaktoren und Therapieoptionen;Frauenheilkunde up2date;2024-08